Microglial proteins in the brain: the good, the bad and the ugly
Late and early-onset AD: understanding the differences
The lack of new data for Alzheimer's disease research: what can be done?
Pieter Jelle Visser
Clearing up: approaches to treat Parkinson's disease
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD